Report Summary
Eternity Insights has published a new study on Global Biologics Market focusing on key segments as by Type (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi), by Application (Infectious Diseases, Oncology, Immunology, Autoimmune Diseases), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Biologics Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Biologics Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Biologics Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Biologics Market Segmentation:
Biologics Market, By Type
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Antisense
- RNAi
Biologics Market, By Application
- Infectious Diseases
- Oncology
- Immunology
- Autoimmune Diseases
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Biologics market in terms of demand generation. The Biologics market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Biologics market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Biologics Market Taxonomy:
To learn more about this report
Global Biologics Market Competitive Landscape
The global Biologics market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Eli Lilly & Company
- Samsung Biologics
- F Hoffman La Roche
- Celltrion
- Addgene
- Amgen
- Abbvie Inc.
- Sanofi
- Pfizer Inc.
- Merck & Co. Inc.
- Novo Nordisk A/S
- Johnson & Johnson Services Inc.
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi |
| By Application Outlook |
Infectious Diseases, Oncology, Immunology, Autoimmune Diseases |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Eli Lilly & Company, Samsung Biologics, F Hoffman La Roche, Celltrion, Addgene, Amgen, Abbvie Inc., Sanofi, Pfizer Inc., Merck & Co. Inc., Novo Nordisk A/S, Johnson & Johnson Services Inc. |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Biologics Market Research Report 2021-2027, by Manufacturers, Regions, Types and Applications
1 Study Coverage
1.1 Biologics Product
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Biologics Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies
1.4.3 Vaccines
1.4.4 Recombinant Proteins
1.4.5 Antisense
1.4.6 RNAi
1.5 Market by Application
1.5.1 Global Biologics Market Size Growth Rate by Application
1.5.2 Infectious Diseases
1.5.3 Oncology
1.5.4 Immunology
1.5.5 Autoimmune Diseases
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biologics Production
2.1.1 Global Biologics Revenue 2017-2027
2.1.2 Global Biologics Production 2017-2027
2.1.3 Global Biologics Capacity 2017-2027
2.1.4 Global Biologics Marketing Pricing and Trends
2.2 Biologics Growth Rate (CAGR) 2021-2027
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Key Biologics Manufacturers
2.4 Market Drivers, Trends and Issues
2.5 Macroscopic Indicator
2.5.1 GDP for Major Regions
2.5.2 Price of Raw Materials in Dollars: Evolution
3 Market Size by Manufacturers
3.1 Biologics Production by Manufacturers
3.1.1 Biologics Production by Manufacturers
3.1.2 Biologics Production Market Share by Manufacturers
3.2 Biologics Revenue by Manufacturers
3.2.1 Biologics Revenue by Manufacturers (2017-2020)
3.2.2 Biologics Revenue Share by Manufacturers (2017-2020)
3.3 Biologics Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Biologics Production by Regions
4.1 Global Biologics Production by Regions
4.1.1 Global Biologics Production Market Share by Regions
4.1.2 Global Biologics Revenue Market Share by Regions
4.2 United States
4.2.1 United States Biologics Production
4.2.2 United States Biologics Revenue
4.2.3 Key Players in United States
4.2.4 United States Biologics Import & Export
4.3 Europe
4.3.1 Europe Biologics Production
4.3.2 Europe Biologics Revenue
4.3.3 Key Players in Europe
4.3.4 Europe Biologics Import & Export
4.4 China
4.4.1 China Biologics Production
4.4.2 China Biologics Revenue
4.4.3 Key Players in China
4.4.4 China Biologics Import & Export
4.5 Japan
4.5.1 Japan Biologics Production
4.5.2 Japan Biologics Revenue
4.5.3 Key Players in Japan
4.5.4 Japan Biologics Import & Export
4.6 Other Regions
4.6.1 South Korea
4.6.2 India
4.6.3 Southeast Asia
5 Biologics Consumption by Regions
5.1 Global Biologics Consumption by Regions
5.1.1 Global Biologics Consumption by Regions
5.1.2 Global Biologics Consumption Market Share by Regions
5.2 North America
5.2.1 North America Biologics Consumption by Application
5.2.2 North America Biologics Consumption by Countries
5.2.3 United States
5.2.4 Canada
5.2.5 Mexico
5.3 Europe
5.3.1 Europe Biologics Consumption by Application
5.3.2 Europe Biologics Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 UK
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Biologics Consumption by Application
5.4.2 Asia Pacific Biologics Consumption by Countries
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Indonesia
5.4.9 Thailand
5.4.10 Malaysia
5.4.11 Philippines
5.4.12 Vietnam
5.5 Central & South America
5.5.1 Central & South America Biologics Consumption by Application
5.5.2 Central & South America Biologics Consumption by Countries
5.5.3 Brazil
5.6 Middle East and Africa
5.6.1 Middle East and Africa Biologics Consumption by Application
5.6.2 Middle East and Africa Biologics Consumption by Countries
5.6.3 Turkey
5.6.4 GCC Countries
5.6.5 Egypt
5.6.6 South Africa
6 Market Size by Type
6.1 Global Biologics Breakdown Dada by Type
6.2 Global Biologics Revenue by Type
6.3 Biologics Price by Type
7 Market Size by Application
7.1 Overview
7.2 Global Biologics Breakdown Dada by Application
7.2.1 Global Biologics Consumption by Application
7.2.2 Global Biologics Consumption Market Share by Application (2017-2020)
8 Manufacturers Profiles
8.1 Eli Lilly & Company
8.1.1 Eli Lilly & Company Company Details
8.1.2 Company Description
8.1.3 Capacity, Production and Value of Biologics
8.1.4 Biologics Product Description
8.1.5 SWOT Analysis
8.2 Samsung Biologics
8.2.1 Samsung Biologics Company Details
8.2.2 Company Description
8.2.3 Capacity, Production and Value of Biologics
8.2.4 Biologics Product Description
8.2.5 SWOT Analysis
8.3 F Hoffman La Roche
8.3.1 F Hoffman La Roche Company Details
8.3.2 Company Description
8.3.3 Capacity, Production and Value of Biologics
8.3.4 Biologics Product Description
8.3.5 SWOT Analysis
8.4 Celltrion
8.4.1 Celltrion Company Details
8.4.2 Company Description
8.4.3 Capacity, Production and Value of Biologics
8.4.4 Biologics Product Description
8.4.5 SWOT Analysis
8.5 Addgene
8.5.1 Addgene Company Details
8.5.2 Company Description
8.5.3 Capacity, Production and Value of Biologics
8.5.4 Biologics Product Description
8.5.5 SWOT Analysis
8.6 Amgen
8.6.1 Amgen Company Details
8.6.2 Company Description
8.6.3 Capacity, Production and Value of Biologics
8.6.4 Biologics Product Description
8.6.5 SWOT Analysis
8.7 Abbvie Inc.
8.7.1 Abbvie Inc. Company Details
8.7.2 Company Description
8.7.3 Capacity, Production and Value of Biologics
8.7.4 Biologics Product Description
8.7.5 SWOT Analysis
8.8 Sanofi
8.8.1 Sanofi Company Details
8.8.2 Company Description
8.8.3 Capacity, Production and Value of Biologics
8.8.4 Biologics Product Description
8.8.5 SWOT Analysis
8.9 Pfizer Inc.
8.9.1 Pfizer Inc. Company Details
8.9.2 Company Description
8.9.3 Capacity, Production and Value of Biologics
8.9.4 Biologics Product Description
8.9.5 SWOT Analysis
8.10 Merck & Co. Inc.
8.10.1 Merck & Co. Inc. Company Details
8.10.2 Company Description
8.10.3 Capacity, Production and Value of Biologics
8.10.4 Biologics Product Description
8.10.5 SWOT Analysis
8.11 Novo Nordisk A/S
8.12 Johnson & Johnson Services Inc.
9 Production Forecasts
9.1 Biologics Production and Revenue Forecast
9.1.1 Global Biologics Production Forecast 2021-2027
9.1.2 Global Biologics Revenue Forecast 2021-2027
9.2 Biologics Production and Revenue Forecast by Regions
9.2.1 Global Biologics Revenue Forecast by Regions
9.2.2 Global Biologics Production Forecast by Regions
9.3 Biologics Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Biologics Production Forecast by Type
9.4.2 Global Biologics Revenue Forecast by Type
10 Consumption Forecast
10.1 Consumption Forecast by Application
10.2 Biologics Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Biologics Consumption Forecast by Countries 2021-2027
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Biologics Consumption Forecast by Countries 2021-2027
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Biologics Consumption Forecast by Countries 2021-2027
10.5.2 China
10.5.3 Japan
10.5.4 Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Biologics Consumption Forecast by Country 2021-2027
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Biologics Consumption Forecast by Countries 2021-2027
10.7.2 Middle East and Africa
10.7.3 Turkey
10.7.4 GCC Countries
10.7.5 Egypt
10.7.6 South Africa
11 Upstream, Industry Chain and Downstream Customers Analysis
11.1 Analysis of Biologics Upstream Market
11.1.1 Biologics Key Raw Material
11.1.2 Typical Suppliers of Key Biologics Raw Material
11.1.3 Biologics Raw Material Market Concentration Rate
11.2 Biologics Industry Chain Analysis
11.3 Marketing & Distribution
11.4 Biologics Distributors
11.5 Biologics Customers
12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter's Five Forces Analysis
13 Key Findings
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
